VIRAMAL LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

Completed
Conditions
Interventions
First Posted Date
2018-12-10
Last Posted Date
2020-10-06
Lead Sponsor
Viramal Limited
Target Recruit Count
14
Registration Number
NCT03770065
Locations
🇺🇸

Medical Affiliated Research Center, Inc. (MARC), Huntsville, Alabama, United States

Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

Phase 1
Conditions
Interventions
First Posted Date
2018-06-14
Last Posted Date
2022-04-27
Lead Sponsor
Viramal Limited
Target Recruit Count
20
Registration Number
NCT03556800
Locations
🇬🇧

Simbec Research Ltd, Merthyr Tydfil, Wales, United Kingdom

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2017-11-24
Last Posted Date
2020-06-12
Lead Sponsor
Viramal Limited
Target Recruit Count
30
Registration Number
NCT03352076
Locations
🇮🇹

Ospedale L. Sacco - Milan-Obgyn Unit, Milan, Italy

© Copyright 2024. All Rights Reserved by MedPath